FILICE, GIAMPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 272
EU - Europa 264
AS - Asia 76
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 616
Nazione #
US - Stati Uniti d'America 272
GB - Regno Unito 52
IT - Italia 49
CN - Cina 43
SE - Svezia 43
IE - Irlanda 40
UA - Ucraina 28
FR - Francia 26
TR - Turchia 17
DE - Germania 12
IN - India 12
BE - Belgio 8
FI - Finlandia 5
VN - Vietnam 4
CL - Cile 2
EU - Europa 2
GR - Grecia 1
Totale 616
Città #
Chandler 62
Dublin 40
Jacksonville 40
Ann Arbor 33
Nanjing 19
Ashburn 17
Dearborn 16
Princeton 16
Southend 12
Izmir 10
Chieti 9
Altamura 8
Beijing 8
Brussels 8
Cambridge 7
Wilmington 7
Nanchang 5
Rome 5
Dong Ket 4
New York 4
Boardman 3
Collecorvino 3
Woodbridge 3
Changsha 2
New Delhi 2
Shenyang 2
Tianjin 2
Augusta 1
Basking Ridge 1
Cavacurta 1
Concordia Sagittaria 1
Council Bluffs 1
Edinburgh 1
Frankfurt am Main 1
Grevenbroich 1
Hangzhou 1
Helsinki 1
Jiaxing 1
Kunming 1
Lanzhou 1
Las Vegas 1
Laurel 1
Los Angeles 1
Milan 1
Orange 1
Paris 1
Pollena Trocchia 1
San Mateo 1
San Vito Chietino 1
Seattle 1
Varallo 1
Washington 1
Zhengzhou 1
Totale 373
Nome #
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 112
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 101
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 95
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 78
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 78
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients 70
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 66
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 54
Totale 654
Categoria #
all - tutte 2.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 2 1 18
2019/2020131 33 5 6 0 10 12 16 5 7 18 15 4
2020/202162 9 4 12 0 0 13 2 1 5 7 0 9
2021/202296 3 3 1 14 7 7 5 8 8 12 5 23
2022/2023161 17 30 13 15 16 31 7 7 13 0 6 6
2023/202468 3 5 4 2 5 21 16 10 0 2 0 0
Totale 654